Attached files
file | filename |
---|---|
EX-5.1 - EX-5.1 - PLUS THERAPEUTICS, INC. | d922631dex51.htm |
S-1 - S-1 - PLUS THERAPEUTICS, INC. | d922631ds1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Plus Therapeutics, Inc.
Austin, TX 78756 USA
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 30, 2020, relating to the consolidated financial statements of Plus Therapeutics, Inc. (the Company) appearing in the Companys Annual Report on Form 10-K for the year ended December 31, 2019. Our report contains an explanatory paragraph regarding the Companys ability to continue as a going concern.
We also consent to the reference to us under the caption Experts in the Prospectus.
/s/ BDO USA, LLP
San Diego, California
October 29, 2020